Phio Announces Key Development Milestone for PH-762 with FDA Submission Supporting Next Stage of Clinical Development in Cutaneous Squamous Cell Carcinoma
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq climbs over 1% as SpaceX, Super Micro boost AI sentiment
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Nvidia’s Huang highlights AI benefits in Berlin speech amid wider European tour
- AI bubble about to burst? Not yet, Yardeni says
| (NASDAQ: PHIO) | Delayed: 0.89 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.89 | 52 Week High | $ | |||
| Open | $0.91 | 52 Week Low | $ | |||
| Day High | $0.92 | P/E | N/A | |||
| Day Low | $0.86 | EPS | $ | |||
| Volume | 92,347 | |||||
